MD Start, a Lausanne, Switzerland-based venture capital- and industry-backed medical device technology incubator, has added medical device company Sorin Group and healthcare venture...
Silhouette, a Swiss leader in fitness clubs, has been acquired by 21 Centrale Partners, in association with SEC Partners. This transaction follows the...
MCI Group Holding SA, a Geneva, Switzerland-based global association, communication and event management group, has completed an €8m equity investment with Iris Capital. ...
Nord Anglia Education, an international provider of education, training and guidance for children and young adults, has received an investment of undisclosed amount from...
Diagnoplex SA, a Lausanne, Switzerland-based developer of molecular diagnostics for colon cancer, has closed a series A financing extension with Debiopharm Group. Under the...
VAXIMM AG, a Basel-Switzerland-based biotech firm focused on developing vaccines for patients suffering from cancer, closed a CHF7.8m financing round. Investors include existing shareholders...
SmallRivers SA, the Lausanne, Switzerland-based developer of Paper.li, a social news publication application, has raised $2.1m in funding.
Investors include Highland Capital Partners, SoftBank Capital...
NovImmune, a Geneva, Switzerland-based drug discovery and development company with a focus on therapeutic monoclonal antibodies (mAbs) for inflammatory diseases and immune-related disorders, has...
Covagen, a Zurich, Switzerland-based company that develops a novel class of protein therapeutics (Fynomers), closed a CHF6.3m Series A financing round. The round was...
Delenex Therapeutics AG, a Zürich-Schlieren, Switzerland-based biotech company developing therapeutic antibody fragments targeting serious medical diseases, has closed its CHF13.5m (approximately US$14m, €10m) Series...
Mind-NRG, a Switzerland-based new company focused on development of a peptidic neurotrophic factor (NRG-101), has closed an up to €10m financing with Index...
